FTC seeks review of a court ruling on generic drug competition
(By Ed Silverman for STAT) T he US Federal Trade Commission has once again waded into a closely watched legal
Read moreA trusted source for Medicare news and education from the AMAC Foundation.
(By Ed Silverman for STAT) T he US Federal Trade Commission has once again waded into a closely watched legal
Read more(By Ed Silverman for ST A T) T he controversial EpiPen device is about to get still more competition. A
Read more(By Judith Graham for Kaiser Health News) Your 65th birthday is coming up. Soon, you think, the government will send
Read more(By Richard Harris for NPR) Researchers have launched an innovative medical experiment that’s designed to provide quick answers while meeting
Read moreGlaxoSmithKline has filed for U.S. regulatory approval for their shingles vaccine Shingrix which has shown greater protection among older recipients
Read moreWith polio on the brink of global eradication, Jon Abramson of World Health Organization stated there are only two manufacturers
Read more(By Ed Silverman for ST A T) C all it Bernie Sanders vs. Ariad Pharmaceuticals, Act Two. The Vermont senator
Read more(By Ed Silverman for ST A T) n the latest development in a heated battle between Gilead Sciences and the
Read more(By Ed Silverman for ST A T) A ny company that plans to mimic the approach taken by Sarepta Therapeutics
Read more(By Richard Harris for NPR) Generic drugs generally cost 80 percent less than brand-name drugs, so hopes were high when
Read more